Journal of Pharmacy And Bioallied Sciences

ORIGINAL ARTICLE
Year
: 2011  |  Volume : 3  |  Issue : 3  |  Page : 397--402

Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats


V Sabitha1, S Ramachandran2, KR Naveen2, K Panneerselvam1 
1 Department of Bioinformatics, Karunya University, Coimbatore, Tamil Nadu, India
2 Department of Pharmacology, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India

Correspondence Address:
K Panneerselvam
Department of Bioinformatics, Karunya University, Coimbatore, Tamil Nadu
India

Objectives : The present investigation was aimed to study the antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus peel and seed powder (AEPP and AESP) in streptozotocin (STZ)-induced diabetic rats. Materials and Methods : Acute toxicity of AEPP and AESP was studied in rats at 2000 mg/kg dose and diabetes was induced in rats by administration of STZ (60 mg/kg, i.p.). After 14 days of blood glucose stabilization, diabetic rats received AEPP, AESP, and glibenclamide up to 28 days. The blood samples were collected on day 28 to estimate the hemoglobin (Hb), glycosylated hemoglobin (HbA1c), serum glutamate-pyruvate transferase (SGPT), total protein (TP), and lipid profile levels. Results : In acute toxicity study, AESP and AESP did not show any toxicity or death up to a dose of 2000 mg/kg. Therefore, to assess the antidiabetic action, one by fifth and one by tenth dose of both powders were selected. Administration of AEPP and AESP at 100 and 200 mg/kg dose in diabetic rats showed significant (P < 0.001) reduction in blood glucose level and increase in body weight than diabetic control rats. A significant (P < 0.001) increased level of Hb, TP, and decreased level of HbA1c, SGPT were observed after the treatment of both doses of AEPP and AESP. Also, elevated lipid profile levels returned to near normal in diabetic rats after the administration of AEPP and AESP, 100 and 200 mg/kg dose, compared to diabetic control rats. Conclusion : The present study results, first time, support the antidiabetic and antihyperlipidemic potential of A. esculentus peel and seed powder in diabetic rats.


How to cite this article:
Sabitha V, Ramachandran S, Naveen K R, Panneerselvam K. Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats.J Pharm Bioall Sci 2011;3:397-402


How to cite this URL:
Sabitha V, Ramachandran S, Naveen K R, Panneerselvam K. Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats. J Pharm Bioall Sci [serial online] 2011 [cited 2020 Jun 3 ];3:397-402
Available from: http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=397;epage=402;aulast=Sabitha;type=0